Health Numinus Files U.S. Provisional Patent Application for a Proprietary Rapid Production Process for Psilocybe and Other Psychoactive Fungi Species June 24, 2021
Health Health Canada Approves Expansion of Mydecine’s Cultivation Capabilities for Psilocybin Producing Mushrooms May 25, 2021
Health MindMed Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical Trial May 17, 2021
Health Numinus Wellness Announces Key Leadership Hires to Support Rapid Growth and Innovation May 13, 2021
Health Numinus Wellness and Optimi Health Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application May 11, 2021
Health Numinus Congratulates MAPS on Phase 3 Clinical Trial Demonstrating Significant Benefits of MDMA-Assisted Therapy for Severe PTSD May 11, 2021
Health WELL’s Clinical Business Unit Expands Corporate and Executive Health Services with Completion of ExecHealth Acquisition May 5, 2021
Health Numinus Wellness Q2 2021 Results Highlighted by $17.25 Million Financing, Mindspace Wellbeing Acquisition and Clinical Trial Collaboration with MAPS PBC April 30, 2021
Health Numinus Announces Listing of Warrants and Change of Trading Symbol for Previously Listed Warrants April 26, 2021
Health Wellteq Appoints Global Corporate Wellness Sales Executive as Chief Growth Officer March 25, 2021
Search
Health
June 24, 2021
May 25, 2021
May 17, 2021
May 13, 2021
May 11, 2021
May 11, 2021
May 5, 2021
April 30, 2021
April 26, 2021
March 25, 2021
